Wearable electric-field device slows aggressive breast cancer in preclinical study

A drug-free exertion that uses low-intensity electrical fields reduces tumor maturation and dispersed successful preclinical models of triple-negative bosom cancer, 1 of the astir assertive forms of the disease, according to caller probe from The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James).